Lincotek Acquires Majority Stake in Danco Medical

Global contract manufacturer Lincotek has closed the acquisition of a majority stake in Danco Medical from Danco Anodizing (Warsaw, IN), strengthening the Medical Division of the group.
 
The scope of the transaction comprises all the service activities focused on metal surface finishing for the medical market and includes the ISO-13485 certified facility in Warsaw, Indiana.
 
Established in the U.S. in 1971 in California and 2001 in Indiana, Danco Medical offers complete, one-stop-shop surface preparation and finishing solutions and a wide range of product identification methods to medical orthopedic device companies. It is also a leader in Aluminum and Titanium Anodizing and offers services comprising ChemFilm, Electropolishing, Passivation Processes and Low Friction Chrome coating. Latest innovative developments include unique deep image graphics for cases and trays and HAnano Surface Treatments.
 
Lincotek Medical offers orthopedic device companies fully integrated supply chain solutions, including device engineering; casting; forging; additive manufacturing; precision machining; plasma spray, calcium phosphate and physical vapor deposition coatings; as well as electrochemical treatments and final packaging.
 
The move will expand the capabilities of Lincotek in the medical field, increasing the company’s manufacturing footprint by one plant (around 35,000 sq ft and 150 employees) – giving the company an even more competitive edge in a wide range of projects.
 
Lincotek Medical and Danco Medical will form a synergistic partnership to offer OEMs a unique combination of services, addressing any needs of orthopedic customers around technical depth and process mastery, offering the highest levels of quality and reliability, optimized lead times and best-in-class customer service. The agreement will increase Lincotek’s presence in the U.S., providing customers an even more integrated and unique approach and allowing OEMs to stay focused on their core business.
 
“This is a perfect match between the two companies,” says Winfried Schaller, the CEO of Lincotek Group, “as we are able to offer a 360-degree service around all possible needs of the global orthopedic device industry. We believe that this will generate a unique platform for the industry, which is addressing major needs around supply chain simplification and lead-time reductions. Effectively offering all supply chain steps from one source.”
 
Danco will remain as an independent unit inside the Lincotek Medical structure. The former owners and the management, will run the company as before, to ensure that the quality and service levels are maintained.
 
“With Danco Medical joining the Lincotek Group, it will strengthen our growth strategies by creating a fully integrated portfolio that will support our customer needs and expectations,” says Ross Tiamson, CEO of Danco Medical. “Our company values are aligned, and are well established – Danco Medical looks forward to this next chapter.”